Table 4 Multivariate final model analysis of the sample of NH residents
| Â | UI | Â | Â | Â | Â | |||
|---|---|---|---|---|---|---|---|---|
| Â | Yes | No | Â | Â | Â | Â | ||
| Â | n | % | n | % | p value | OR (CI:95%) | p value | Adjusted OR (CI:95%) |
Cognitive capacity | Â | Â | Â | Â | Â | Â | Â | Â |
 Normal/Slight | 24 | 57.1 | 18 | 42.9 |  |  |  | reference |
 Moderate/ Severe | 77 | 85.6 | 13 | 14.4 | < 0.001 | 4.44 (1.90-10.37) | 0.003 | 4.25 (1.66–10.91) |
Anticholinergic activity | Â | Â | Â | Â | Â | Â | Â | Â |
 No | 30 | 62.5 | 18 | 37.56 | 30 |  |  | reference |
 Yes (moderate/very high) | 70 | 85.4 | 12 | 14.65 | 0.005 | 3.50 (1.50–8.16) | 0.004 | 4.01 (1.57–10.23) |
Risk of Sarcopenia (SARC-F) | Â | Â | Â | Â | Â | Â | Â | Â |
 No | 18 | 58.1 | 13 | 41.9 | 18 |  |  | reference |
 Yes | 82 | 82.0 | 18 | 18.09 | 0.006 | 3.29 (1.36–7.90) | 0.041 | 2.75 (1.04–7.30) |